Literature DB >> 1437917

Cardiac enzymes. How to use serial determinations to confirm acute myocardial infarction.

R S Ruzich1.   

Abstract

Although acute myocardial infarction can be diagnosed on the basis of clinical history, electrocardiographic (ECG) findings, and abnormalities of creatine kinase (CK) and lactate dehydrogenase (LDH) enzyme levels, measurement of cardiac enzyme levels is the most reliable way to confirm or exclude the diagnosis. If the MB isoenzyme of creatine kinase (CK-MB) remains normal during the 48 hours after the suspected clinical event, acute myocardial infarction can be reliably ruled out; if CK-MB values become elevated and the LDH isoenzyme pattern (LDH2:LDH1 ratio) becomes "flipped," the diagnosis can reliably be made. However, if CK-MB values become elevated but the LDH isoenzyme pattern remains normal, the diagnosis is less firm and ECG and myocardial imaging techniques may be needed to confirm or exclude myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437917     DOI: 10.1080/00325481.1992.11701533

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  4 in total

Review 1.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

2.  Diagnostic markers of acute myocardial infarction.

Authors:  Sabesan Mythili; Narasimhan Malathi
Journal:  Biomed Rep       Date:  2015-07-29

Review 3.  Emerging biomarkers for the detection of cardiovascular diseases.

Authors:  Sreenu Thupakula; Shiva Shankar Reddy Nimmala; Haritha Ravula; Sudhakar Chekuri; Raju Padiya
Journal:  Egypt Heart J       Date:  2022-10-20

4.  Long noncoding RNA-MEG3 contributes to myocardial ischemia-reperfusion injury through suppression of miR-7-5p expression.

Authors:  Liyuan Zou; Xiaokun Ma; Shuo Lin; Bingyuan Wu; Yang Chen; Chaoquan Peng
Journal:  Biosci Rep       Date:  2019-08-19       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.